2026 NPPES data Medical Oncology Physician NPI 1811296668 M.D.
Verify on CMS →

BOLANLE ADEPOJU, M.D.

Medical Oncology Physician in GOSHEN, Indiana. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
511
Medicare Part D claims · 184 beneficiaries · Medical Oncology Physician avg: 689
Generic prescribing
88%
generic claims · 12% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$2.4K
14 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

BOLANLE ADEPOJU, M.D. filed 511 Medicare Part D claims in 2023 as a Medical Oncology Physician in GOSHEN, Indiana, prescribing 88% generic.

511
Part D claims, 2023
88%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

BOLANLE ADEPOJU, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

511 Top 34% higher than 66% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). This entry sits in this band. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

BOLANLE ADEPOJU, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about BOLANLE ADEPOJU, M.D.?

Quality data not reported

NPI registry status

Active

Issued 03/18/2011

NPI 1811296668

Primary specialty

Medical Oncology Physician

Niche

3,792 US NPIs in this specialty

Medicare Part D claims

511 26% vs specialty avg

2023 prescription claims

Specialty avg: 689

Specialty distribution in Indiana

How Medical Oncology Physician compares to other specialties among Indiana providers

Indiana providers

Medical Oncology Physician share within Indiana

1. Medical Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Medical Oncology Physician share within Indiana

Specialty board-certification context

Estimated specialty board-certified rate — Medical Oncology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Medical Oncology Physician ABMS/AOA estimate

Est. board-certified rate (Medical Oncology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Medical Oncology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

BOLANLE ADEPOJU, M.D. appears in the CMS NPPES registry as a Medical Oncology Physician provider holding M.D. credentials at 200 HIGH PARK AVE, GOSHEN, IN, 46526, with a listed phone of (574) 364-2888. NPI 1811296668 was issued on 03/18/2011. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ADEPOJU most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 511 prescription claims written by this provider, covering 184 Medicare beneficiaries and totaling roughly $752K in drug spend, split 12% brand-name and 88% generic by claim count, with an opioid prescribing rate of 4.3%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Medical Oncology Physician is a narrow specialty nationwide, with 3,792 enrolled providers across 53 states and an average of 689 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

200 HIGH PARK AVE
GOSHEN, IN 46526

Provider Details

NPI 1811296668
Specialty Medical Oncology Physician
Credentials M.D.
Gender Female
NPI Issued 03/18/2011

Hospital and facility affiliations

Facilities where BOLANLE ADEPOJU, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

GOSHEN HEALTH SYSTEM INC
GOSHEN, IN

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for BOLANLE ADEPOJU, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$2.4K

Largest payer

Novartis Pharmaceuticals Corporation

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

BOLANLE ADEPOJU, M.D. — brand share 12.0%
Specialty average (est.)

12% brand-name claims vs 88% generic, on 511 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

511
Total Claims
$752K
Total Drug Cost
184
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,015
Total Day Supply
28,134
Brand vs Generic
12% brand / 88% generic
Brand Drug Cost
$629K
Generic Drug Cost
$123K
Opioid Claims
22 (4.3% rate)
Antibiotic Claims
13

Patient Demographics

Average Patient Age
71.8 years
Avg HCC Risk Score
1.54
Gender Split
88% female / 12% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What BOLANLE ADEPOJU, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Anastrozole
177
Letrozole
31
Potassium Chloride
26
Exemestane
24
Tamoxifen Citrate
23
Valacyclovir
Valacyclovir Hcl
13
Dexamethasone
12
Ibrance
Palbociclib
12
Omeprazole
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Medical Oncology Physician Overview

How BOLANLE ADEPOJU, M.D. fits within the Medical Oncology Physician landscape nationally.

3,792
Medical Oncology Physician Providers in US
53
States with Medical Oncology Physician
689
Avg Claims per Provider

BOLANLE ADEPOJU, M.D.'s 511 claims are below the specialty average of 689.

Nearby Medical Oncology Physician Providers in Indiana

Other clinicians with the same primary specialty enrolled in Indiana, drawn from the same CMS NPPES roster as ADEPOJU.

Compare Medical Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is BOLANLE ADEPOJU, M.D.'s specialty?
BOLANLE ADEPOJU, M.D. specializes in Medical Oncology Physician and practices in GOSHEN, Indiana. Credentials: M.D..
How much does BOLANLE ADEPOJU, M.D. prescribe under Medicare Part D?
In 2023, BOLANLE ADEPOJU, M.D. wrote 511 Medicare Part D claims totaling $752K in drug costs for 184 beneficiaries.
Where is BOLANLE ADEPOJU, M.D. located?
BOLANLE ADEPOJU, M.D. is located at 200 HIGH PARK AVE, GOSHEN, IN, 46526. Phone: (574) 364-2888.
What is BOLANLE ADEPOJU, M.D.'s NPI number?
BOLANLE ADEPOJU, M.D.'s National Provider Identifier (NPI) is 1811296668, issued on 03/18/2011.
Does BOLANLE ADEPOJU, M.D. prescribe more brand-name or generic drugs?
BOLANLE ADEPOJU, M.D.'s prescribing is 12% brand-name and 88% generic drugs by claim count, with $629K in brand drug costs.
Does BOLANLE ADEPOJU, M.D. prescribe opioids?
Yes, BOLANLE ADEPOJU, M.D. had 22 opioid claims in 2023 with an opioid prescribing rate of 4.3%.
How many Medical Oncology Physician providers are there in the US?
There are 3,792 Medical Oncology Physician providers across 53 states in the US. The average Medical Oncology Physician provider writes 689 Medicare Part D claims per year.
What drugs does BOLANLE ADEPOJU, M.D. prescribe most often?
Based on 2023 Medicare Part D data, BOLANLE ADEPOJU, M.D.'s most frequently prescribed drugs include Anastrozole, Letrozole, Potassium Chloride. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does BOLANLE ADEPOJU, M.D. accept Medicare?
BOLANLE ADEPOJU, M.D. appears in CMS Medicare data with 511 Part D claims and 184 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify BOLANLE ADEPOJU, M.D.'s credentials?
BOLANLE ADEPOJU, M.D.'s NPI is 1811296668 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology